Laurence M. Corash - Mar 1, 2022 Form 4 Insider Report for CERUS CORP (CERS)

Role
Chief Scientific Officer
Signature
Laurence M. Corash by Chrystal Menard, attorney-in-fact
Stock symbol
CERS
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/3/2022, 06:40 PM
Previous filing
Dec 21, 2021
Next filing
Mar 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CERS Restricted Stock Unit Award $0 +45K +2.22% $0.00 2.07M Mar 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERS Option (Right to Buy) Award +90K 90K Mar 1, 2022 Common Stock 90K $5.76 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
F2 One fourth (1/4th) of the shares subject to the Option shall vest on the first anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter.
F3 Not applicable.